Intellia Therapeutics Market Sentiment

Intellia Therapeutics Inc

NTLANASDAQ

Trade with Public

$12.60

0.897.6%

最終更新: Oct 8, 6:14 PM

$12.55

0.847.17%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Intellia Therapeutics Market Sentiment - Benzinga

Intellia Therapeutics Market Sentiment

Market sentiment signals for Intellia Therapeutics (NTLA): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 42.0% short float

Options Flow▲ 0.17 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

29 analysts

Options Flow (P/C)

0.17

More calls — Bullish

845 calls · 141 puts

Avg Consensus PT

$25

+96.7%

Highest Price Target

$65

+417.9%

Cantor Fitzgerald

Lowest Price Target

-60.2%

JP Morgan

Short Interest

42.0%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 6, 2026	Barclays	Eliana Merle—	-36.3%	$8	Initiate	Underweight
Sep 9, 2026	Citizens	Silvan Turkcan—	+139.0%	$30 → $30	Maintained	Market Outperform
Sep 9, 2026	Wedbush	David Nierengarten—	+3.6%	$12 → $13	Maintained	Neutral
Sep 9, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+99.2%	$25 → $25	Maintained	Buy
Aug 25, 2026	Citizens	Silvan Turkcan—	+139.0%	$30 → $30	Maintained	Market Outperform
Aug 7, 2026	Evercore ISI Group	Jonathan Miller—	+91.2%	$16 → $24	Upgrade	In-Line→Outperform
Jul 16, 2026	Wolfe Research	Andy Chen—	-28.3%	$9	Downgrade	Peer Perform→Underperform
Jul 10, 2026	Wedbush	David Nierengarten—	+35.5%	$12 → $17	Maintained	Neutral
Jun 16, 2026	Canaccord Genuity	Whitney Ijem—	+290.4%	$49 → $49	Maintained	Buy
Jun 15, 2026	Citizens	Silvan Turkcan—	+139.0%	$30 → $30	Maintained	Market Outperform
Jun 15, 2026	Wedbush	David Nierengarten—	-4.4%	$12 → $12	Maintained	Neutral
Jun 15, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+99.2%	$25 → $25	Maintained	Buy
May 13, 2026	Bernstein	William Pickering—	+35.5%	$13 → $17	Maintained	Market Perform
May 13, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+99.2%	$30 → $25	Maintained	Buy
May 12, 2026	Canaccord Genuity	Whitney Ijem—	+290.4%	$58 → $49	Maintained	Buy
May 12, 2026	Wedbush	David Nierengarten—	-4.4%	$12 → $12	Maintained	Neutral
Apr 28, 2026	Canaccord Genuity	Whitney Ijem—	+362.2%	$48 → $58	Maintained	Buy
Apr 28, 2026	Goldman Sachs	Salveen Richter—	-28.3%	$8 → $9	Maintained	Sell
Apr 28, 2026	Morgan Stanley	Terence Flynn—	+19.5%	$11 → $15	Maintained	Equal-Weight
Apr 28, 2026	Citizens	Silvan Turkcan—	+139.0%	$28 → $30	Maintained	Market Outperform
Apr 27, 2026	Chardan Capital	Geulah Livshits—	+139.0%	$27 → $30	Maintained	Buy
Apr 27, 2026	Baird	Jack Allen —	+3.6%	$7 → $13	Maintained	Neutral
Mar 4, 2026	Jones Trading	Debanjana Chatterjee—	+131.1%	$29	Upgrade	Hold→Buy
Mar 3, 2026	Canaccord Genuity	Whitney Ijem—	+282.5%	$54 → $48	Maintained	Buy
Mar 3, 2026	Leerink Partners	Mani Foroohar—	+131.1%	$27 → $29	Maintained	Outperform